The FDA approved a human papillomavirus self-collection test that can be gathered in private rooms in primary care offices, urgent care clinics and pharmacies, The Washington Post reported May 15.
The Latest
More centers are testing the effectiveness of vaccines on a range of cancers.
North Carolina nonprofit hospitals are under scrutiny for overcharging for oncology drugs they purchased through a federal discount program meant to help disadvantaged patients, Port City Daily reported May 14.
Los Angeles, Calif.-based Cedars-Sinai Cancer named Indrin Chetty, PhD, vice chair of research and director of the medical physics division.
American Shared Hospital Services acquired three Rhode Island radiation centers.
New research, which has not been peer-reviewed yet, found colorectal cancer rates have risen between 45% and 500% for people too young for routine screenings, though the overall cancer incidences are still low, NBC News reported May 9.
Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami have developed a nanoparticle that can cross the blood-brain barrier, potentially opening the door for new treatments for brain metastases.
Health professionals in Alabama aim to eliminate cervical cancer in the state in a decade, The Wall Street Journal reported May 6.
The University of Texas MD Anderson Cancer Center in Houston has received a $20 million gift from a longtime donor that will go toward advancing research on Alzheimer's and other types of neurodegenerative diseases.
The FDA is urging drug companies to pinpoint the cancer drug dosage that has the greatest impact with the fewest side effects. Its most recent study scrutinizes the dosage of a lung cancer drug, The Washington Post reported May 6.